Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/74876
Title: Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms
Authors: Lazaro, Iolanda
Lopez-Sanz, Laura
Bernal, Susana
Oguiza, Ainhoa
Recio Cruz, Carlota Pilar 
Melgar, Ana
Jimenez-Castilla, Luna
Egido, Jesus
Madrigal-Matute, Julio
Gomez-Guerrero, Carmen
UNESCO Clasification: 3207 Patología
Keywords: Autophagy
Diabetes complications
Inflammation
Nuclear factor (erythroid-derived 2)-like 2
Redox balance
Issue Date: 2018
Journal: Frontiers in Pharmacology 
Abstract: Interactive relationships between metabolism, inflammation, oxidative stress, and autophagy in the vascular system play a key role in the pathogenesis of diabetic cardiovascular disease. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a stress-sensitive guarantor of cellular homeostasis, which cytoprotective contributions extend beyond the antioxidant defense. We investigated the beneficial effects and underlying mechanisms of the Nrf2 inducer tert-butyl hydroquinone (tBHQ) on diabetes-driven atherosclerosis. In the experimental model of streptozotocin-induced diabetes in apolipoprotein E-deficient mice, treatment with tBHQ increased Nrf2 activity in macrophages and vascular smooth muscle cells within atherosclerotic lesions. Moreover, tBHQ significantly decreased the size, extension and lipid content of atheroma plaques, and attenuated inflammation by reducing lesional macrophages (total number and M1/M2 phenotype balance), foam cell size and chemokine expression. Atheroprotection was accompanied by both systemic and local antioxidant effects, characterized by lower levels of superoxide anion and oxidative DNA marker 8-hydroxy-2′-deoxyguanosine, reduced expression of NADPH oxidase subunits, and increased antioxidant capacity. Interestingly, tBHQ treatment upregulated the gene and protein expression of autophagy-related molecules and also enhanced autophagic flux in diabetic mouse aorta. In vitro, Nrf2 activation by tBHQ suppressed cytokine-induced expression of pro-inflammatory and oxidative stress genes, altered macrophage phenotypes, and promoted autophagic activity. Our results reinforce pharmacological Nrf2 activation as a promising atheroprotective approach in diabetes, according to the plethora of cytoprotective mechanisms involved in the resolution of inflammation and oxidative stress, and restoring autophagy.
URI: http://hdl.handle.net/10553/74876
ISSN: 1663-9812
DOI: 10.3389/fphar.2018.00819
Source: Frontiers in Pharmacology [ISSN 1663-9812], v. 9, 819
Appears in Collections:Artículos
Thumbnail
Adobe PDF (3,47 MB)
Show full item record

Page view(s)

29
checked on May 17, 2021

Download(s)

13
checked on May 17, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.